The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis

Long-Term Experimental Evolution in Escherichia coli. I. Adaptation and Divergence During 2,000 Generations

Lenski, R. E., Rose, M. R., Simpson, S. C., & Tadler, S. C. (1991) · The American Naturalist · doi:10.1086/285289 · Cited by 1,582 · see citing works

Humans as the World's Greatest Evolutionary Force

Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290 · see citing works

Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update

Ramaswamy, S. V., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,099 · see citing works

Variable host–pathogen compatibility in Mycobacterium tuberculosis

Gagneux, S., DeRiemer, K., Vân, T. T. T., Kato‐Maeda, M., de Jong, B. C., Narayanan, S., Nicol, M. P., Niemann, S., Kremer, K., Gutierrez, M. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511240103 · Cited by 984 · see citing works

The biological cost of antibiotic resistance

Andersson, D. I., & Levin, B. R. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00005-3 · Cited by 861 · see citing works

Whole-Genome Comparison ofMycobacterium tuberculosisClinical and Laboratory Strains

Fleischmann, R. D., Alland, D., Eisen, J. A., Carpenter, L. R., White, O. R., Peterson, J., DeBoy, R. T., Dodson, R. J., Gwinn, M. L., Haft, D. H., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5479-5490.2002 · Cited by 667 · see citing works

Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori

Björkholm, B., Sjölund, M., Falk, P. G., Berg, O. G., Engstrand, L. G., & Andersson, D. I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241517298 · Cited by 404 · see citing works

Molecular Epidemiology of Tuberculosis

Barnes, P. F., & Cave, M. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021964 · Cited by 390 · see citing works

Programmes and principles in treatment of multidrug-resistant tuberculosis

Mukherjee, J. S., Rich, M., Socci, A. R., Joseph, J. K., Virú, F. A. A., Shin, S. S., Furin, J. J., Becerra, M. C., Barry, D. J., Kim, J. Y., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15496-2 · Cited by 333 · see citing works

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

Dye, C., Williams, B. G., Espinal, M., & Raviglione, M. C. (2002) · Science · doi:10.1126/science.1063814 · Cited by 314 · see citing works

Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness

Cohen, T., & Murray, M. B. (2004) · Nature Medicine · doi:10.1038/nm1110 · Cited by 281 · see citing works

Compensatory Evolution in Rifampin-Resistant <i>Escherichia coli</i>

Reynolds, M. G. (2000) · Genetics · doi:10.1093/genetics/156.4.1471 · Cited by 266 · see citing works

Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution

Maisnier‐Patin, S., & Andersson, D. I. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.01.019 · Cited by 259 · see citing works

Reducing antibiotic resistance

Schrag, S. J., & Perrot, V. (1996) · Nature · doi:10.1038/381120b0 · Cited by 258 · see citing works

Physiological Cost of Rifampin Resistance Induced In Vitro in Mycobacterium tuberculosis

Billington, O. J., McHugh, T. D., & Gillespie, S. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1866 · Cited by 252 · see citing works

Genomic Deletions Classify the Beijing/W Strains as a Distinct Genetic Lineage of Mycobacterium tuberculosis

Tsolaki, A. G., Gagneux, S., Pym, A. S., de la Salmonière, Y.-O. L. G., Kreiswirth, B. N., van Soolingen, D., & Small, P. M. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3185-3191.2005 · Cited by 250 · see citing works

Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis

Mariam, D. H., Mengistu, Y., Hoffner, S. E., & Andersson, D. I. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1289-1294.2004 · Cited by 248 · see citing works

Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance

Blower, S. M., & Chou, T. (2004) · Nature Medicine · doi:10.1038/nm1102 · Cited by 216 · see citing works

Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations

Sander, P., Springer, B., Prammananan, T., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1204-1211.2002 · Cited by 214 · see citing works

Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis

Baker, L. V., Brown, T., Maiden, M. C. J., & Drobniewski, F. A. (2004) · Emerging infectious diseases · doi:10.3201/eid1009.040046 · Cited by 213 · see citing works

Will tuberculosis become resistant to all antibiotics?

Dye, C., & Espinal, M. (2001) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2000.1328 · Cited by 140 · see citing works

Fitness of antibiotic-resistant microorganisms and compensatory mutations

Böttger, E. C., Springer, B., Pletschette, M., & Sander, P. (1998) · Nature Medicine · doi:10.1038/3906 · Cited by 138 · see citing works

Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus

Wichelhaus, T. A., Böddinghaus, B., Besier, S. M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3381-3385.2002 · Cited by 113 · see citing works

AMELIORATION OF THE DELETERIOUS PLEIOTROPIC EFFECTS OF AN ADAPTIVE MUTATION INBACILLUS SUBTILIS

Cohan, F. M., King, E. C., & Zawadzki, P. (1994) · Evolution · doi:10.1111/j.1558-5646.1994.tb01296.x · Cited by 95 · see citing works

Genetic Polymorphism inMycobacterium tuberculosisIsolates from Patients with Chronic Multidrug‐Resistant Tuberculosis

Post, F. A., Willcox, P. A., Mathema, B., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/421501 · Cited by 76 · see citing works

Overview of Resistance in the 1990s

File, T. M. (1999) · CHEST Journal · doi:10.1378/chest.115.suppl_1.3s · Cited by 74 · see citing works

Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?

O’Sullivan, D. M., McHugh, T. D., & Gillespie, S. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki069 · Cited by 59 · see citing works

Amelioration of the Deleterious Pleiotropic Effects of an Adaptive Mutation in Bacillus subtilis

Cohan, F. M., King, E. C., & Zawadzki, P. (1994) · Evolution · doi:10.2307/2410005 · Cited by 40 · see citing works

Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review

Tiemersma, E. W., van der Werf, M. J., Borgdorff, M. W., Williams, B. G., & Nagelkerke, N. J. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017601 · Cited by 583 · see citing works

Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.

Ford, C. B., Shah, R. R., Maeda, M. K., Gagneux, S., Murray, M. B., Cohen, T., Johnston, J. C., Gardy, J., Lipsitch, M., & Fortune, S. M. (2013) · Nature Genetics · doi:10.1038/ng.2656 · Cited by 457 · see citing works

The evolution of drug resistance in clinical isolates of Candida albicans.

Ford, C. B., Funt, J. M., Abbey, D., Issi, L., Guiducci, C., Martinez, D. A., Delorey, T., Li, B. Y., White, T. C., Cuomo, C., et al. (2015) · eLife · doi:10.7554/elife.00662 · Cited by 348 · see citing works

Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence

Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works

Developing insights into the mechanisms of evolution of bacterial pathogens from whole-genome sequences

Bryant, J., Chewapreecha, C., & Bentley, S. D. (2012) · Future Microbiology · doi:10.2217/fmb.12.108 · Cited by 98 · see citing works

Fitness Trade-Offs Associated with the Evolution of Resistance to Antifungal Drug Combinations

Hill, J. A., O’Meara, T. R., & Cowen, L. E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.009 · Cited by 80 · see citing works

Fatal Breakthrough Candidemia in an Immunocompromised Patient in Kuwait Due to Candida auris Exhibiting Reduced Susceptibility to Echinocandins and Carrying a Novel Mutation in Hotspot-1 of FKS1

Al-Obaid, I., Asadzadeh, M., Ahmad, S., Alobaid, K., Alfouzan, W., Bafna, R., Emara, M., & Joseph, L. (2022) · Journal of Fungi · doi:10.3390/jof8030267 · Cited by 39 · see citing works

Establishment of a multidrug resistance cell line of human bladder carcinoma T24/ADM and its multidrug resistant mechanisms

Chen, C. (2011) · Medical Journal of West China

The development of the reversal of the tumor multidrug resistance

Li-wu, F. (2005) · Zhongguo yaolixue tongbao · Cited by 1 · see citing works

EXPRESSION AND CLINICAL SIGNIFICANCE OF MULTIDRUG RESISTANCE GENE AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN ACUTE LEUKEMIA

赖永榕, 马劼, 卢玉英, et al. (1999) · Acta Scientiarum Naturalium Universitatis Sunyatseni

The Effect of Inoculum Size on Proliferation of NCTC Strain 2071, the Chemically Defined Medium Strain of NCTC Clone 929 (Strain L)

Fioramonti, M. C., Evans, V. J., & Earle, W. R. (1958) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/21.3.579 · Cited by 11 · see citing works

A Molecular Basis for Multidrug-Resistance and Reversal of the Resistance

Akiyama, S., Yoshimura, A., Ichikawa, M., et al. (1991) · Springer eBooks · doi:10.1007/978-4-431-68150-2_6 · Cited by 1 · see citing works